Tutorials
FibroGen Inc logo

FibroGen Inc

$ 14.49 +0.44 (+3.13%) 08:08 PM EST
P/E:
At Loss
P/B:
13.09
Market Cap:
$ 1.36B
Enterprise V:
$ 1.01B
Volume:
581.70K
Avg Vol (2M):
802.71K
Also Trade In:
Volume:
581.70K
Market Cap $:
1.36B
PE Ratio:
At Loss
Avg Vol (2-Month):
802.71K
Enterprise Value $:
1.01B
PB Ratio:
13.09
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

FibroGen Inc
NAICS : 325412 SIC : 2834
409 Illinois Street, San Francisco, CA, USA, 94158
Description
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
Name Current Vs Industry Vs History
Cash-To-Debt 4.66
Equity-to-Asset 0.15
Debt-to-Equity 0.91
Debt-to-EBITDA -0.45
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.59
Distress
Grey
Safe
Beneish M-Score -3.46
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 66.37
9-Day RSI 66.6
14-Day RSI 65.51
6-1 Month Momentum % -22.85
12-1 Month Momentum % -3.97

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.17
Quick Ratio 2
Cash Ratio 1.82
Days Inventory 706.75
Days Sales Outstanding 43.03
Days Payable 689.33

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.8

Financials (Next Earnings Date:2022-11-09 Est.)

FGEN's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:FGEN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 263.149
EPS (TTM) ($) -2.37
Beta 0.47
Volatility % 45.79
14-Day RSI 65.51
14-Day ATR ($) 0.750667
20-Day SMA ($) 13.108
12-1 Month Momentum % -3.97
52-Week Range ($) 7.81 - 16.91
Shares Outstanding (Mil) 93.74

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

FibroGen Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More